Loss of SUFU function in familial multiple meningioma.

Meningiomas are the most common primary tumors of the CNS and account for up to 30% of all CNS tumors. An increased risk of meningiomas has been associated with certain tumor-susceptibility syndromes, especially neurofibromatosis type II, but no gene defects predisposing to isolated familial meningiomas have thus far been identified. Here, we report on a family of five meningioma-affected siblings, four of whom have multiple tumors. No NF2 mutations were identified in the germline or tumors. We combined genome-wide linkage analysis and exome sequencing, and we identified in suppressor of fused homolog (Drosophila), SUFU, a c.367C>T (p.Arg123Cys) mutation segregating with the meningiomas in the family. The variation was not present in healthy controls, and all seven meningiomas analyzed displayed loss of the wild-type allele according to the classic two-hit model for tumor-suppressor genes. In silico modeling predicted the variant to affect the tertiary structure of the protein, and functional analyses showed that the activity of the altered SUFU was significantly reduced and therefore led to dysregulated hedgehog (Hh) signaling. SUFU is a known tumor-suppressor gene previously associated with childhood medulloblastoma predisposition. Our genetic and functional analyses indicate that germline mutations in SUFU also predispose to meningiomas, particularly to multiple meningiomas. It is possible that other genic mutations resulting in aberrant activation of the Hh pathway might underlie meningioma predisposition in families with an unknown etiology.

[1]  L. Ruel,et al.  Variations in Hedgehog signaling: divergence and perpetuation in Sufu regulation of Gli. , 2009, Genes & development.

[2]  A. Rosenthal,et al.  Characterization of the human suppressor of fused, a negative regulator of the zinc-finger transcription factor Gli. , 1999, Journal of cell science.

[3]  A. Lophatananon,et al.  Comprehensive analysis of DNA repair gene variants and risk of meningioma. , 2008, Journal of the National Cancer Institute.

[4]  E. Löhr,et al.  Multiple meningiomas. Clinical and computed tomographic observations , 2005, Neuroradiology.

[5]  T. Curran,et al.  Loss of suppressor-of-fused function promotes tumorigenesis , 2007, Oncogene.

[6]  M. Wolter,et al.  Mutation of the PTEN (MMAC1) tumor suppressor gene in a subset of glioblastomas but not in meningiomas with loss of chromosome arm 10q. , 1998, Cancer research.

[7]  S. Henikoff,et al.  Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm , 2009, Nature Protocols.

[8]  F. Baas,et al.  Germline SMARCB1 mutation and somatic NF2 mutations in familial multiple meningiomas , 2010, Journal of Medical Genetics.

[9]  M. Lauth,et al.  Genetic elimination of Suppressor of fused reveals an essential repressor function in the mammalian Hedgehog signaling pathway. , 2006, Developmental cell.

[10]  M. Clementi,et al.  Identification of a SUFU germline mutation in a family with Gorlin syndrome , 2009, American journal of medical genetics. Part A.

[11]  David Hogg,et al.  Mutations in SUFU predispose to medulloblastoma , 2002, Nature Genetics.

[12]  G. García Martín,et al.  [Multiple meningiomas]. , 2007, Neurologia.

[13]  A. Look,et al.  Amplification of the gli gene in childhood sarcomas. , 1989, Cancer research.

[14]  A. Hofman,et al.  Incidental findings on brain MRI in the general population. , 2007, The New England journal of medicine.

[15]  J. Barnholtz-Sloan,et al.  CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011. , 2012, Neuro-oncology.

[16]  P. Bork,et al.  A method and server for predicting damaging missense mutations , 2010, Nature Methods.

[17]  Joseph Wiemels,et al.  Epidemiology and etiology of meningioma , 2010, Journal of Neuro-Oncology.

[18]  J. Taipale,et al.  Patched acts catalytically to suppress the activity of Smoothened , 2002, Nature.

[19]  P. Fischer,et al.  Frequency and risk factors for meningioma in clinically healthy 75‐year‐old patients , 2004, Cancer.

[20]  Jussi Taipale,et al.  Hedgehog: functions and mechanisms. , 2008, Genes & development.

[21]  D. Evans,et al.  SMARCB1 mutations are not a common cause of multiple meningiomas , 2010, Journal of Medical Genetics.

[22]  Jussi Taipale,et al.  Divergence of hedgehog signal transduction mechanism between Drosophila and mammals. , 2006, Developmental cell.

[23]  M. Ultsch,et al.  Suppressor of Fused Regulates Gli Activity through a Dual Binding Mechanism , 2004, Molecular and Cellular Biology.

[24]  D. Krause,et al.  Mammalian Suppressor-of-Fused modulates nuclear–cytoplasmic shuttling of GLI-1 , 1999, Nature Cell Biology.

[25]  G. Tate,et al.  A new germline mutation of the PTCH gene in a Japanese patient with nevoid basal cell carcinoma syndrome associated with meningioma. , 2003, Japanese journal of clinical oncology.

[26]  M. Scott,et al.  Effects of oncogenic mutations in Smoothened and Patched can be reversed by cyclopamine , 2000, Nature.

[27]  G. Abecasis,et al.  Merlin—rapid analysis of dense genetic maps using sparse gene flow trees , 2002, Nature Genetics.

[28]  I. Salmon,et al.  Gene Expression Profiling of the Hedgehog Signaling Pathway in Human Meningiomas , 2010, Molecular medicine.

[29]  Kevin Cowtan,et al.  research papers Acta Crystallographica Section D Biological , 2005 .